journal
Journals Drug Delivery and Translationa...

Drug Delivery and Translational Research

https://read.qxmd.com/read/38519828/in-vivo-evaluation-of-a-nano-enabled-therapeutic-vitreous-substitute-for-the-precise-delivery-of-triamcinolone-to-the-posterior-segment-of-the-eye
#21
JOURNAL ARTICLE
Kruti Naik, Lisa Claire du Toit, Naseer Ally, Yahya Essop Choonara
This study focused on the design of a thermoresponsive, nano-enabled vitreous substitute for the treatment of retinal diseases. Synthesis of a hydrogel composed of hyaluronic acid and a poloxamer blend was undertaken. Poly(D,L-lactide-co-glycolide) acid nanoparticles encapsulating triamcinolone acetonide (TA) were synthesised with a spherical morphology and mean diameter of ~ 153 nm. Hydrogel fabrication and nanoparticle loading within the hydrogel was confirmed via physicochemical analysis. Gelation studies indicated that hydrogels formed in nine minutes and 10 min for the unloaded and nanoparticle-loaded hydrogels, respectively...
March 22, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38517568/poly-malic-acid-budesonide-nanoconjugates-embedded-in-microparticles-for-lung-administration
#22
JOURNAL ARTICLE
Barbara Tessier, Laurence Moine, Arnaud Peramo, Nicolas Tsapis, Elias Fattal
To improve the therapeutic activity of inhaled glucocorticoids and reduce potential side effects, we designed a formulation combining the advantages of nanoparticles, which have an enhanced uptake by alveolar cells, allow targeted delivery and sustained drug release, as well as limited drug systemic passage, with those of microparticles, which display good alveolar deposition. Herein, a polymer-drug conjugate, poly(malic acid)-budesonide (PMAB), was first synthesized with either 11, 20, 33, or 43 mol% budesonide (drug:polymer from 1:8 to 3:4), the drug creating hydrophobic domains...
March 22, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38509343/high-mobility-group-box-1-cytokine-targeted-topical-delivery-of-resveratrol-embedded-nanoemulgel-for-the-management-of-atopic-dermatitis
#23
JOURNAL ARTICLE
Shweta Nene, Geetanjali Devabattula, Ganesh Vambhurkar, Kamatham Pushpa Tryphena, Pankaj Kumar Singh, Dharmendra Kumar Khatri, Chandraiah Godugu, Saurabh Srivastava
Resveratrol is a polyphenolic compound showing anti-inflammatory activity by inhibition of high mobility group box 1 cytokine responsible for the activation of nuclear factor-κB pathway in atopic dermatitis. To evaluate the efficacy of resveratrol through topical route we have developed resveratrol-loaded nanoemulgel for the effective management of atopic dermatitis in mice model. The resveratrol-loaded nanoemulsion (0.5%, 0.75% and 1% w/w) was optimized by spontaneous nano-emulsification. The optimized resveratrol-loaded nanoemulsions showed average globule size in the 180-230 nm range and found to be monodispersed...
March 20, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38509342/microfluidic-based-systems-for-the-management-of-diabetes
#24
REVIEW
Shuyu Zhang, Anne E Staples
Diabetes currently affects approximately 500 million people worldwide and is one of the most common causes of mortality in the United States. To diagnose and monitor diabetes, finger-prick blood glucose testing has long been used as the clinical gold standard. For diabetes treatment, insulin is typically delivered subcutaneously through cannula-based syringes, pens, or pumps in almost all type 1 diabetic (T1D) patients and some type 2 diabetic (T2D) patients. These painful, invasive approaches can cause non-adherence to glucose testing and insulin therapy...
March 20, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38507033/evaluation-of-mab-2c5-modified-dendrimer-based-micelles-for-the-co-delivery-of-sirna-and-chemotherapeutic-drug-in-xenograft-mice-model
#25
JOURNAL ARTICLE
Satya Siva Kishan Yalamarty, Nina Filipczak, Tanvi Pathrikar, Colin Cotter, Janaína Artem Ataide, Ed Luther, Swarali Paranjape, Vladimir Torchilin
Combination therapy with small interfering RNA (siRNA) and chemotherapeutic drug is proven to be effective in downregulating cancer resistance proteins, such as P-glycoprotein (P-gp). These proteins are involved in multidrug resistance (MDR) of tumors. A targeted formulation capable of delivering siRNA and chemotherapeutic drug will not only downregulate P-gp but also increase the concentration of the chemotherapeutic drug at the site of tumor thereby increasing the therapeutic effect and lowering the systemic exposure...
March 20, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38502267/enhancing-collagen-based-nanoemulgel-for-effective-topical-delivery-of-aceclofenac-and-citronellol-oil-formulation-optimization-in-vitro-evaluation-and-in-vivo-osteoarthritis-study-with-a-focus-on-hmgb-1-rage-nf-%C3%AE%C2%BAb-pathway-klotho-and-mir-499a
#26
JOURNAL ARTICLE
Reem Abd Elhameed Aldeeb, Sherihan Salaheldin Abdelhamid Ibrahim, Islam Ahmed Khalil, Ghada Mohamed Ragab, Amira Ahmed El-Gazar, Amal Anwar Taha, Doaa Hussien Hassan, Asmaa Ahmed Gomaa, Mona Kamal Younis
The majority of conventional osteoarthritis (OA) treatments are based on molecular adjustment of certain signaling pathways associated with osteoarthritis (OA) pathogenesis, however there is a significant need to search for more effective and safe treatments. This study centers around formulating Aceclofenac (ACF) with high bioavailability in combination with Citronellol oil and collagen. The optimal concentrations of Citronellol oil/D-Limonene oil, Tween 80, and Transcutol HP were determined using a pseudoternary phase diagram...
March 19, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38498080/rgd-coated-polymeric-microbubbles-promote-ultrasound-mediated-drug-delivery-in-an-inflamed-endothelium-pericyte-co-culture-model-of-the-blood-brain-barrier
#27
JOURNAL ARTICLE
Christopher Hark, Junlin Chen, Julia Blöck, Eva Miriam Buhl, Harald Radermacher, Robert Pola, Michal Pechar, Tomáš Etrych, Quim Peña, Anne Rix, Natascha I Drude, Fabian Kiessling, Twan Lammers, Jan-Niklas May
Drug delivery to central nervous pathologies is compromised by the blood-brain barrier (BBB). A clinically explored strategy to promote drug delivery across the BBB is sonopermeation, which relies on the combined use of ultrasound (US) and microbubbles (MB) to induce temporally and spatially controlled opening of the BBB. We developed an advanced in vitro BBB model to study the impact of sonopermeation on the delivery of the prototypic polymeric drug carrier pHPMA as a larger molecule and the small molecule antiviral drug ribavirin...
March 18, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38494558/imatinib-glycymicelles-entrapped-in-hydrogel-preparation-characterization-and-therapeutic-effect-on-corneal-alkali-burn-in-mice
#28
JOURNAL ARTICLE
Yanan Wang, Shaohua Shi, Ling Zhang, Songtao Wang, Hongqing Qin, Yanjun Wei, Xianggen Wu, Mengmeng Zhang
Imatinib (IMB) is a type of tyrosine kinase inhibitor with great application potential for inhibiting corneal neovascularization (CNV), but its poor water solubility limits its application in eye disease treatment. In this study, novel IMB@glycymicelles entrapped in hydrogel (called IMB@glycymicelle-hydrogel) were prepared, characterized, and evaluated for their therapeutic effects on corneal alkali burn in mice. Imatinib could be successfully loaded in glycymicelles using glycyrrhizin as a nanocarrier with an optimized weight ratio of IMB:nanocarrier...
March 17, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38478324/ox26-cojugated-gangliosilated-liposomes-to-improve-the-post-ischemic-therapeutic-effect-of-cdp-choline
#29
JOURNAL ARTICLE
Nicola d'Avanzo, Donatella Paolino, Antonella Barone, Luigi Ciriolo, Antonia Mancuso, Maria Chiara Christiano, Anna Maria Tolomeo, Christian Celia, Xiaoyong Deng, Massimo Fresta
Cerebrovascular impairment represents one of the main causes of death worldwide with a mortality rate of 5.5 million per year. The disability of 50% of surviving patients has high social impacts and costs in long period treatment for national healthcare systems. For these reasons, the efficacious clinical treatment of patients, with brain ischemic stroke, remains a medical need. To this aim, a liposome nanomedicine, with monosialic ganglioside type 1 (GM1), OX26 (an anti-transferrin receptor antibody), and CDP-choline (a neurotrophic drug) (CDP-choline/OX26Lip) was prepared...
March 13, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38472727/imiquimod-nanocrystal-loaded-dissolving-microneedles-prepared-by-dlp-printing
#30
JOURNAL ARTICLE
Eliška Petrová, Stanislav Chvíla, František Štěpánek, Jarmila Zbytovská, Dimitrios A Lamprou
The utilization of 3D printing- digital light processing (DLP) technique, for the direct fabrication of microneedles encounters the problem of drug solubility in printing resin, especially if it is predominantly composed of water. The possible solution how to ensure ideal belonging of drug and water-based printing resin is its pre-formulation in nanosuspension such as nanocrystals. This study investigates the feasibility of this approach on a resin containing nanocrystals of imiquimod (IMQ), an active used in (pre)cancerous skin conditions, well known for its problematic solubility and bioavailability...
March 12, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38472726/cyclosporin-a-loaded-dissolving-microneedles-for-dermatitis-therapy-development-characterisation-and-efficacy-in-a-delayed-type-hypersensitivity-in-vivo-model
#31
JOURNAL ARTICLE
Miquel Martínez-Navarrete, Antonio José Guillot, Maria C Lobita, María Carmen Recio, Rosa Giner, Juan Aparicio-Blanco, María Carmen Montesinos, Hélder A Santos, Ana Melero
Several drugs can be used for treating inflammatory skin pathologies like dermatitis and psoriasis. However, for the management of chronic and long-term cases, topical administration is preferred over oral delivery since it prevents certain issues due to systemic side effects from occurring. Cyclosporin A (CsA) has been used for this purpose; however, its high molecular weight (1202 Da) restricts the diffusion through the skin structure. Here, we developed a nano-in-micro device combining lipid vesicles (LVs) and dissolving microneedle array patches (DMAPs) for targeted skin delivery...
March 12, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38459422/correction-biosafety-evaluation-of-etoposide-lipid-nanomedicines-in-c-elegans
#32
Souhaila H El Moukhtari, Amanda Muñoz-Juan, Rubén Del Campo-Montoya, Anna Laromaine, María J Blanco-Prieto
No abstract text is available yet for this article.
March 8, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38457026/dynamic-intervention-to-enhance-the-stability-of-pegylated-ibrutinib-loaded-lipidic-nano-vesicular-systems-transitioning-from-colloidal-dispersion-to-lyophilized-product
#33
JOURNAL ARTICLE
Kanan Panchal, Akhila Reddy, Rishi Paliwal, Akash Chaurasiya
Liposomes being a promising colloidal system facilitates delivery of drugs with limited pharmacokinetic properties to achieve desirable clinical applications. However, development of a stable liposomal system is always challenging due to multiple complexities involved. Aqueous instability of liposomes and impact of various process and formulation parameters can lead to serious alteration of its therapeutic performance. In the proposed work, the authors aim to develop stable Ibrutinib-loaded liposomes using lyophilization and Quality-by-Design and assess their long-term stability...
March 8, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38457025/oxaliplatin-lipidated-prodrug-synergistically-enhances-the-anti-colorectal-cancer-effect-of-il12-mrna
#34
JOURNAL ARTICLE
Hui Liu, Yating Du, Desheng Zhan, Wenjun Yu, Yan Li, Aiping Wang, Jianpeng Yin, Haiqiang Cao, Yuanlei Fu
Colorectal cancer (CRC) is the fourth most common cancer in the world, with the second highest incidence rate after lung cancer. Oxaliplatin (OXA) is a broad-spectrum anti-tumor agent with significant therapeutic efficacy in colorectal cancer, and as a divalent platinum analog, it is not selective in its distribution in the body and has systemic toxicity with continued use. Interleukin-12 (IL12) is an immunostimulatory cytokine with cytokine monotherapy that has made advances in the fight against cancer, limiting the clinical use of cytokines due to severe toxicity...
March 8, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38451440/nanocrystals-and-nanosuspensions-an-exploration-from-classic-formulations-to-advanced-drug-delivery-systems
#35
JOURNAL ARTICLE
Benjamin Rossier, Olivier Jordan, Eric Allémann, Carlos Rodríguez-Nogales
Nanocrystals and nanosuspensions have become realistic approaches to overcome the formulation challenges of poorly water-soluble drugs. They also represent a less-known but versatile platform for multiple therapeutic applications. They can be integrated into a broad spectrum of drug delivery systems including tablets, hydrogels, microneedles, microparticles, or even functionalized liposomes. The recent progresses, challenges, and opportunities in this field are gathered originally together with an informative case study concerning an itraconazole nanosuspension-in-hydrogel formulation...
March 7, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38446352/liver-fibrosis-pathologies-and-potentials-of-rna-based-therapeutics-modalities
#36
JOURNAL ARTICLE
Rimpy Diwan, Samantha Lynn Gaytan, Himanshu Narendrakumar Bhatt, Jacqueline Pena-Zacarias, Md Nurunnabi
Liver fibrosis (LF) occurs when the liver tissue responds to injury or inflammation by producing excessive amounts of scar tissue, known as the extracellular matrix. This buildup stiffens the liver tissue, hinders blood flow, and ultimately impairs liver function. Various factors can trigger this process, including bloodborne pathogens, genetic predisposition, alcohol abuse, non-steroidal anti-inflammatory drugs, non-alcoholic steatohepatitis, and non-alcoholic fatty liver disease. While some existing small-molecule therapies offer limited benefits, there is a pressing need for more effective treatments that can truly cure LF...
March 6, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38441832/insulin-delivery-to-the-brain-via-the-nasal-route-unraveling-the-potential-for-alzheimer-s-disease-therapy
#37
REVIEW
Chun Yuen Jerry Wong, Alberto Baldelli, Camilla M Hoyos, Ole Tietz, Hui Xin Ong, Daniela Traini
This comprehensive review delves into the potential of intranasal insulin delivery for managing Alzheimer's Disease (AD) while exploring the connection between AD and diabetes mellitus (DM). Both conditions share features of insulin signalling dysregulation and oxidative stress that accelerate inflammatory response. Given the physiological barriers to brain drug delivery, including the blood-brain barrier, intranasal administration emerges as a non-invasive alternative. Notably, intranasal insulin has shown neuroprotective effects, impacting Aβ clearance, tau phosphorylation, and synaptic plasticity...
March 5, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38431532/innovative-freeze-drying-technique-in-the-fabrication-of-dissolving-microneedle-patch-enhancing-transdermal-drug-delivery-efficiency
#38
JOURNAL ARTICLE
Tong Su, Zequn Tang, Jiayi Hu, Yuyu Zhu, Teng Shen
Microneedle patch (MNP) has become a hot research topic in the field of transdermal drug delivery due to its ability to overcome the stratum corneum barrier. Among the various types of microneedles, dissolving microneedles represent one of the most promising transdermal delivery methods. However, the most used method for preparing dissolving microneedles, namely microfabrication, suffers from issues such as long drying time, susceptibility to humidity, and large batch-to-batch variability, which limit the development of dissolving microneedles...
March 2, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38430357/preparation-and-characterization-of-sorafenib-nano-emulsion-impact-on-pharmacokinetics-and-toxicity-an-in-vitro-and-in-vivo-study
#39
JOURNAL ARTICLE
Dalia Zaafar, Heba M A Khalil, Gehad E Elkhouly, Abanoub Selim Sedeky, Yasmine H Ahmed, Mona G Khalil, Yasmin Abo-Zeid
Hepatocellular carcinoma (HCC) ranks as the third leading cause of cancer-related deaths worldwide. Current treatment strategies include surgical resection, liver transplantation, liver-directed therapy, and systemic therapy. Sorafenib (Sor) is the first systemic drug authorized by the US Food and Drug Administration (FDA) for HCC treatment. Nevertheless, the conventional oral administration of Sor presents several limitations: poor solubility, low bioavailability, drug resistance development, and off-target tissue accumulation, leading to numerous adverse effects...
March 2, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38427275/plga-pei-nanoparticle-covered-with-poly-i-c-for-personalised-cancer-immunotherapy
#40
JOURNAL ARTICLE
Lorena Gonzalez-Melero, Edorta Santos-Vizcaino, Ruben Varela-Calvino, Iria Gomez-Tourino, Aintzane Asumendi, Maria Dolores Boyano, Manoli Igartua, Rosa Maria Hernandez
Melanoma is the main cause of death among skin cancers and its incidence worldwide has been experiencing an appalling increase. However, traditional treatments lack effectiveness in advanced or metastatic patients. Immunotherapy, meanwhile, has been shown to be an effective treatment option, but the rate of cancers responding remains far from ideal. Here we have developed a personalized neoantigen peptide-based cancer vaccine by encapsulating patient derived melanoma neoantigens in polyethylenimine (PEI)-functionalised poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) and coating them with polyinosinic:polycytidylic acid (poly(I:C))...
March 1, 2024: Drug Delivery and Translational Research
journal
journal
43242
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.